{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T06:01:22Z","timestamp":1769925682915,"version":"3.49.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["obesityresearchclinicalpractice.com","mdconsult.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Obesity Research & Clinical Practice"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.orcp.2013.11.008","type":"journal-article","created":{"date-parts":[[2013,12,17]],"date-time":"2013-12-17T16:15:12Z","timestamp":1387296912000},"page":"e571-e576","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Antiobesity drugs in early pregnancy and congenital malformations in the offspring"],"prefix":"10.1016","volume":"8","author":[{"given":"Bengt A.J.","family":"K\u00e4ll\u00e9n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.orcp.2013.11.008_bib0005","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/bdra.20620","article-title":"Maternal obesity and morbid obesity: the risk for birth defects in the offspring","volume":"88","author":"Blomberg","year":"2010","journal-title":"Birth Def Res A"},{"key":"10.1016\/j.orcp.2013.11.008_bib0010","series-title":"Birth Defects and Drugs in Pregnancy","author":"Heinonen","year":"1977"},{"key":"10.1016\/j.orcp.2013.11.008_bib0015","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S0140-6736(70)91765-4","article-title":"Dexamphetamine: a possible environmental trigger in cardiovascular malformations","volume":"I","author":"Nora","year":"1970","journal-title":"Lancet"},{"key":"10.1016\/j.orcp.2013.11.008_bib0020","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0002-9378(76)90601-3","article-title":"Effects of antenatal exposure to anorectic drugs","volume":"125","author":"Milkovich","year":"1976","journal-title":"Am J Obst Gynecol"},{"key":"10.1016\/j.orcp.2013.11.008_bib0025","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/tera.10023","article-title":"Pregnancy outcomes after first trimester exposure to phentermine\/flenfluramine","volume":"65","author":"Jones","year":"2002","journal-title":"Teratology"},{"key":"10.1016\/j.orcp.2013.11.008_bib0030","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/bdra.20052","article-title":"Sibutramine use in pregnancy: report of two cases","volume":"70","author":"Kadioglu","year":"2004","journal-title":"Birth Def Res A"},{"key":"10.1016\/j.orcp.2013.11.008_bib0035","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejogrb.2004.02.035","article-title":"Exposure to sibutramine during pregnancy: a case series","volume":"116","author":"Einarson","year":"2004","journal-title":"Eur J Obst Gynecol Reprod Biol"},{"key":"10.1016\/j.orcp.2013.11.008_bib0040","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ejogrb.2005.02.016","article-title":"Sibutramine in pregnancy","volume":"122","author":"Ramzi","year":"2005","journal-title":"Eur J Obst Gynecol Reprod Biol"},{"key":"10.1016\/j.orcp.2013.11.008_bib0045","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2165\/00002018-200629030-00008","article-title":"Early first-trimester sibutramine exposure: pregnancy outcome and neonatal follow-up","volume":"29","author":"De Santis","year":"2006","journal-title":"Drug Saf"},{"key":"10.1016\/j.orcp.2013.11.008_bib0050","first-page":"277","article-title":"Preliminary data on pregnancy outcome following exposure to drugs for the treatment of obesity in pregnancy","volume":"22","author":"McEllhatton","year":"2006","journal-title":"Reprod Toxicol"},{"issue":"Suppl. 3","key":"10.1016\/j.orcp.2013.11.008_bib0055","first-page":"101","article-title":"Appetite suppressants in pregnancy","volume":"13","author":"Ma\u00f1akov\u00e1","year":"2012","journal-title":"Neuroendocrinol Lett"},{"key":"10.1016\/j.orcp.2013.11.008_bib0060","series-title":"Centre for Epidemiology. The Swedish Medical Birth Register \u2013 a summary of content and quality","author":"National Board of Health and Welfare","year":"2003"},{"key":"10.1016\/j.orcp.2013.11.008_bib0065","series-title":"Centre for Epidemiology. Registration of congenital malformations in Swedish health registers","author":"National Board of Health and Welfare","year":"2004"},{"key":"10.1016\/j.orcp.2013.11.008_bib0070","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1365-2125.2006.02574.x","article-title":"QT interval prolongation associated with sibutramine treatment","volume":"61","author":"Harrison-Woolrych","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.orcp.2013.11.008_bib0075","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1345\/aph.1L129","article-title":"Sibutramine-associated QT interval prolongation and cardiac arrest","volume":"42","author":"Ernest","year":"2008","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.orcp.2013.11.008_bib0080","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/tera.1084","article-title":"Stage-specific skeletal and visceral defects of the Ikr-blocker almokalant: further evidence for teratogenicity via a hypoxia-related mechanism","volume":"64","author":"Sk\u00f6ld","year":"2001","journal-title":"Teratology"},{"key":"10.1016\/j.orcp.2013.11.008_bib0085","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.reprotox.2010.01.014","article-title":"Improved methodology for identifying the teratogenic potential in early drug development of hERG channel blocking drugs","volume":"29","author":"Nilsson","year":"2010","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.orcp.2013.11.008_bib0090","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/cvr\/cvs296","article-title":"Exploration of human, rat, and rabbit embryonic cardiomyocytes suggests K-channel block as a common teratogenic mechanism","volume":"97","author":"Danielsson","year":"2013","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.orcp.2013.11.008_bib0095","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.reprotox.2005.01.010","article-title":"Is erythromycin therapy teratogenic in humans?","volume":"20","author":"K\u00e4ll\u00e9n","year":"2005","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.orcp.2013.11.008_bib0100","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1017\/S0033291709992194","article-title":"Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data","volume":"10","author":"Reis","year":"2010","journal-title":"Psychol Med"}],"container-title":["Obesity Research & Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871403X13002184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871403X13002184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T18:53:20Z","timestamp":1716317600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871403X13002184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S1871403X13002184"],"URL":"https:\/\/doi.org\/10.1016\/j.orcp.2013.11.008","relation":{},"ISSN":["1871-403X"],"issn-type":[{"value":"1871-403X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiobesity drugs in early pregnancy and congenital malformations in the offspring","name":"articletitle","label":"Article Title"},{"value":"Obesity Research & Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.orcp.2013.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Asian Oceanian Association for the Study of Obesity. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}